Compare ICUI & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICUI | PLSE |
|---|---|---|
| Founded | 1984 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.6B |
| IPO Year | 1995 | 2015 |
| Metric | ICUI | PLSE |
|---|---|---|
| Price | $159.20 | $49.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 6 |
| Target Price | ★ $193.38 | $54.00 |
| AVG Volume (30 Days) | 209.0K | ★ 565.6K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.62 | N/A |
| EPS | ★ 1.96 | N/A |
| Revenue | ★ $2,231,262,000.00 | N/A |
| Revenue This Year | N/A | $477.71 |
| Revenue Next Year | $4.44 | $233.00 |
| P/E Ratio | $82.31 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $112.50 | $12.56 |
| 52 Week High | $192.85 | $58.90 |
| Indicator | ICUI | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 42.35 | 48.04 |
| Support Level | $152.02 | $49.01 |
| Resistance Level | $160.22 | $57.82 |
| Average True Range (ATR) | 4.47 | 3.22 |
| MACD | 0.32 | -0.78 |
| Stochastic Oscillator | 41.28 | 22.44 |
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.